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Abstract
The focal adhesion docking protein NEDD9/HEF1/Cas-L regulates cell migration and cancer invasion. NEDD9 is a member of
the Cas family of proteins that share conserved overall protein-protein interaction domain structure, including a substrate
domain that is characterized by extensive tyrosine (Y) phosphorylation. Previous studies have suggested that
phosphorylation of Y253 in the substrate domain of the Cas family protein p130Cas is specifically required for p130Cas
function in cell migration. While it is clear that tyrosine phosphorylation of the NEDD9 substrate domain is similarly required
for the regulation of cell motility, whether individual NEDD9 tyrosine residues have discrete function in regulating motility
has not previously been reported. In the present study we have used a global sequence alignment of Cas family proteins to
identify a putative NEDD9 equivalent of p130Cas Y253. We find that NEDD9 Y189 aligns with p130Cas Y253 and that it is
conserved among NEDD9 vertebrate orthologues. Expression of NEDD9 in which Y189 is mutated to phenylalanine results
in increased rates of cell migration and is correlated with increased disassembly of GFP.NEDD9 focal adhesions. Conversely,
mutation to Y189D significantly inhibits cell migration. Our previous data has suggested that NEDD9 stabilizes focal
adhesions and the present data therefore suggests that phosphorylation of Y189 NEDD9 is required for this function. These
findings indicate that the individual tyrosine residues of the NEDD9 substrate domain may serve discrete functional roles.
Given the important role of this protein in promoting cancer invasion, greater understanding of the function of the
individual tyrosine residues is important for the future design of approaches to target NEDD9 to arrest cancer cell invasion.
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Introduction
The Cas family protein NEDD9/HEF1/Cas-L has emerged as
a critical regulator of cancer invasion and metastasis in a variety of
different cancers [1]. NEDD9 promotes elongated, adhesion-
dependent invasion in 3D environments [2] and our previous work
has suggested that NEDD9 stabilizes focal adhesions, thereby
contributing to the adhesion forces that are required for the
elongated mode of invasion [3]. The expression and regulation of
NEDD9 is highly controlled (reviewed in [4]) and, together with
other related members of the Cas family proteins, is subject to
extensive phosphorylation modifications. Of particular interest is
the substrate binding domain that contains multiple consensus sites
for tyrosine phosphorylation [5]. Recent data have suggested that
individual tyrosine residues within the substrate domain of the
related protein p130Cas/BCAR1 may be associated with discrete
functional outputs [6,7]. Currently, the role of individual tyrosine
residues within the substrate domain of NEDD9 is unknown.
The Cas family proteins include NEDD9, p130Cas, Efs/Sin
and the most recently described member HEPL/CASS4 [8]. They
are grouped together based on an overall conserved protein-
protein interaction domain structure. Each of the family members
contain a highly conserved N-terminal SH3 domain, followed by a
less conserved substrate domain containing multiple tyrosine
residues, a serine-rich region and a well-conserved C-terminal
domain that has structural similarity with the Focal Adhesion
Targeting (FAT) domain of FAK (reviewed in [9]). NEDD9,
p130Cas and HEPL localize to focal adhesions via targeting
information encompassed in both the SH3 and C-terminal FAT
domains [10–12]. Included among prominent functions for
NEDD9 and p130Cas is a role in cell migration, both in normal
and pathological conditions (reviewed in [1]).
The substrate domains of both NEDD9 and p130Cas are highly
tyrosine phosphorylated in response to adhesion to integrin ligands
and as a result of constitutive activation of regulatory kinases
including FAK and Src [4]. NEDD9 binds to FAK at focal
adhesions and FAK phosphorylation of the DYDY motif in the
NEDD9 c-terminus creates a binding site for Src kinase, which
then catalyzes phosphorylation of tyrosines in the NEDD9
substrate domain. Phosphorylation of the NEDD9 substrate
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domain is required for T-lymphocyte [13,14] and glioblastoma
[15] cell migration. Similarly, the p130Cas substrate domain is
required for p130Cas promotion of cell migration [16] and
mutation of all 15 consensus tyrosine phosphorylation sites to
phenylalanine (F) abrogates p130Cas-mediated migration [7,17].
Y253 in the substrate domain of mouse p130Cas (equivalent to
Y249 in the human sequence) was found to be the most highly
phosphorylated residue by Src tyrosine kinase [6]. Correspond-
ingly, Y to F mutation of Y253 significantly inhibited the ability of
p130Cas to promote migration; although the effect of this
mutation may be context dependent [7]. More recently, mutation
of mouse p130Cas Y253 was shown to specifically affect migration
on vitronectin and combined mutation of Y253 p130Cas together
with a second site in the substrate domain were sufficient to inhibit
in vivo metastasis [18]. Together, these data provide evidence that
single amino acid residues in the substrate domain may regulate
migration down-stream from Cas proteins.
We recently reported that mouse embryo fibroblasts (MEFs)
from NEDD92/2 mice have faster rates of focal adhesion
disassembly and correspondingly migrate more rapidly on 2D
surfaces [3]. In the present study, we therefore questioned whether
individual tyrosine residues in the NEDD9 substrate domain may
play a role in regulating NEDD9-mediated cell migration and
focal adhesion dynamics. Using a global sequence alignment
strategy, we identified NEDD9 Y189 in alignment with p130Cas
Y253 and therefore analysed the effect of mutating this residue on
NEDD9 function. We show that mutation of Y189 to phenylal-
anine (F) to inhibit phosphorylation, results in increased rates of
assembly and disassembly of NEDD9-positive focal adhesions and
demonstrate that this correlates with increased rates of cell
migration. Conversely, the phosphomimetic construct, Y189D,
significantly inhibits cell migration. By contrast, a second NEDD9
tyrosine residue, chosen for analysis as it does not align with a
corresponding tyrosine phosphorylation motif in p130Cas, had no
effect on focal adhesion dynamics and cell migration.
Results
Given the role of mouse p130CasY253 in the regulation of
p130Cas-mediated cell migration, we questioned whether there
may be a functional equivalent of this residue in NEDD9. To
assess potential conserved tyrosines between the Cas protein family
members we performed a global sequence alignment of multiple
vertebrate isoforms (human, mouse, rat and chicken) of the 4 Cas
family members (Figure S1). A portion of this alignment,
encompassing p130CasY253 (human p130Cas Y249), is shown
(Figure 1A). The alignment reveals that p130Cas Y249 is
conserved between each of the p130Cas orthologues. Moreover,
Y189 of human NEDD9 aligns with human p130Cas Y249 and is
conserved in all 4 vertebrate NEDD9 orthologues in the alignment
(Figure 1A). Interestingly, comparison of the 13 NEDD9 tyrosine
residues located in the substrate binding domain (amino acids 59–
399), between the SH3 domain (amino acids 1–58) and the SRR
domain (amino acids 400–462), reveals considerable concordance
between the positions of NEDD9 and p130Cas tyrosines (Table 1).
Of the 13 NEDD9 tyrosines, 10 show conservation with p130Cas
tyrosine residues in the global alignment (although frequently the
tyrosine residue is absent from the chicken p130Cas orthologue).
Notably, NEDD9 Y166 and Y317 are both conserved in all Cas
protein family sequences. Generally, the pattern of concordance is
less between NEDD9 tryosine residues and Efs (7/13 tyrosines)
and NEDD9 and HEPL (4/13 tyrosines).
As an indication of whether Y189NEDD9 is phosphorylated
in vivo we analysed publicly available data at the PhosphositePlus
website. This revealed frequent detection of phosphorylated
NEDD9Y189 in high throughput mass-spectrometry based
screens in a variety of different cancer cell types (Figure 1B). We
further compared the total number of records reporting the
detection of this phosphosite with other NEDD9 residues and it
was the 7th most frequently detected NEDD9 phosphorylation site
in the phosphosite database (detected in .100 records, Table 2).
To test the hypothesis that individual tyrosine residues within the
NEDD9 substrate domain may have discrete functional outcomes
it was necessary to select an additional NEDD9 tyrosine to allow
us to compare downstream phenotypes. Thus, for this purpose we
chose NEDD9 Y214 (detected in .200 records, Table 2) that
displayed no alignment with tyrosines in any of the other Cas
proteins and therefore might be expected to serve a NEDD9-
specific function. Analysis of phosphopeptide data at Phosphosi-
tePlus also confirmed frequent detection of phosphorylated human
p130Cas Y249 (detected in .600 records, Table 3) and NEDD9
Y214 in a variety of cancer cell lines (Figure 1B). These data
therefore provide evidence that these sites may be bona fide
phosphorylation targets in vivo.
To analyse the effect of the individual tyrosines, NEDD9
expression constructs were generated in which either Y189 or
Y214 were mutated to phenylalanine (Y189F and Y214F) to
prevent phosphorylation (Figure 2A). The effect of the individual
mutations on total NEDD9 phosphorylation was determined by
plating cells in suspension (FN-) followed by plating on fibronectin
(+) to stimulate adhesion and corresponding tyrosine phosphory-
lation. Similar levels of tyrosine phosphorylation were induced by
adhesion in either exogenously expressed mutant proteins and in
the wild-type NEDD9 exogenous control (Figure 2B), reflecting
the large number of tyrosines in the substrate domain. Moreover,
comparison of the sub-cellular distribution of GFP-tagged NEDD9
fusion proteins with paxillin-positive focal adhesions revealed that
both NEDD9Y189F and NEDD9Y214F are efficiently targeted to
focal adhesions (Figure 2C). Therefore, mutation of the either
tyrosine residues does not appear to block global adhesion-
dependent NEDD9 tyrosine phosphorylation and neither are they
required for NEDD9 localization to focal adhesions.
Next, we analysed the role of NEDD9 Y189 and NEDD9 Y214
in the promotion of cell migration. NEDD92/2 mouse embryo
fibroblasts were transfected with pGFP.NEDD9, pGFP.NEDD9
Y189F and pGFP.NEDD9 Y214F and individual migrating cells
were imaged by time-lapse microscopy. Analysis of the migration
paths traced by the cells indicated that cells expressing NEDD9
Y189F elaborated extensive migration paths (Figure 3A). Quan-
tification of the Mean Squared Displacement (MSD) revealed that
the cells expressing NEDD9 Y189F have significantly faster
migration speed than cells expressing wild-type exogenous
NEDD9 (Figure 3B and 3C). By contrast, migration paths of cells
expressing NEDD9 Y214F were less extensive (Figure 3A) and
quantification of MSD for these cells confirmed that their speed is
not significantly different to control cells transfected with wild-type
NEDD9 (Figure 3B and 3C).
Having previously demonstrated that NEDD9 expression
regulates focal adhesion dynamics [3] we hypothesized that faster
cell migration speeds induced by expression of NEDD9 Y189F
may reflect faster focal adhesion turnover induced by this
mutation. Therefore, we analysed GFP.NEDD9 Y189F positive
focal adhesions in NEDD92/2 MEFs by time-lapse microscopy
(Figure 4A). Quantification indicates that GFP.NEDD9Y189F-
positive adhesions assemble more rapidly than wild-type
GFP.NEDD9 adhesions (Figure 4B). Similarly, they disassembled
more rapidly than their wild-type counterparts (Figure 4C). In
contrast, GFP.NEDD9 Y214F positive adhesions have the same
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Figure 1. Cas family protein alignment and tyrosine phosphorylation. A. Cas family protein sequences aligned at the PRALINE website.
Shown is the region of alignment encompassing human p130CasY249 (LAPGPQDIyDVPPVRGL) indicated by an asterisk and underlined. Numbers
above the alignments refer to amino acid number in the NEDD9 human protein sequence, from human NEDD9 residue G144 to A234. The two
highlighted tyrosine residues (Y189, Y214) indicate the two NEDD9 residues of interest. Shading indicates the degree of sequence conservation, with
red (10) indicating the greatest conservation as shown in the colour gradient at the bottom of the figure. The full sequence alignment is shown in
Figure S1. B. Summary of high throughput tandem mass spectrometry studies from phosphosite plus that report detection of phosphorylated NEDD9
Y189, p130Cas Y249 and NEDD9 Y214. Data accessed and analysed as per the materials and methods. Numbers (n) = the number of non-redundant
positive records for each site. Pie charts show the representative distributions of the positive records between the different tumour cell types.
doi:10.1371/journal.pone.0069304.g001
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rates of assembly and disassembly as GFP.NEDD9 adhesions
(Figure 4B and 4C). Thus the faster migration speed stimulated by
GFP.NEDD9 Y189F expression is correlated with increased
assembly and disassembly of GFP.NEDD9 Y189F focal adhesions.
Together, these data suggest that phosphorylation of NEDD9
Y189F may be critical to NEDD9 regulation of focal adhesion
dynamics and cell migration speed.
To next confirm whether phosphorylation of Y189 is sufficient
to regulate cell migration speed, we tested the effect of the
phospho-mimetic, Y189D (Figure 5A). Importantly, this mutation
did not affect NEDD9 targeting to focal adhesions (Figure 5B).
Time-lapse imaging of transfected cells, followed by cell tracking
revealed that indeed this mutation significantly reduced cell
migration speed, when compared with cells transfected with wild-
type GFP.NEDD9 (Figure 5C). Given our data showing that
NEDD9Y189F-positive focal adhesions had more rapid dynamics
than their wild-type counterparts, we questioned whether the
phospho-mimetic GFP.NEDD9Y189D positive focal adhesions
may have reduced dynamics when compared with wild-type
GFP.NEDD9 adhesions. Careful analysis of the focal adhesions
after time-lapse imaging failed to reveal a change in the dynamics
of GFP.NEDD9Y189D-positive adhesions. However, it was noted
that the GFP.NEDD9Y189D focal adhesions appeared to be more
uniform in size than their wild-type counterparts. Thus we
compared focal adhesion lengths in regions of protruding cell
membrane. This analysis revealed an apparent dichotomy in the
focal adhesion size, with a greater frequency of longer GFP.NED-
D9Y189D less that 4 mm long and conversely a greater frequency
of longer GFP.NEDD9 focal adhesions greater than 4 mm
(Figure 5D). Indeed, comparison of the focal adhesions less than
4 mm long, revealed that the GFP.NEDDY189D focal adhesions
are significantly longer in this fraction of the population
(Figure 5E). Thus the data suggest that GFP.NEDD9Y189D focal
adhesions are more tightly clustered around lengths of 4 mm.
Discussion
Previous studies have suggested an important role for
phosphorylation of Y253 mouse/Y249 human p130Cas in the
regulation of cell migration. Using a global sequence alignment
strategy we identified that Y189 in the human NEDD9 substrate
domain appears to be conserved with Y249 of human p130Cas.
We further show that NEDD9 Y189 appears to contribute to focal
adhesion dynamics and cell migration. Thus our study has
identified a unique role for a single amino acid residue in the
substrate domain of NEDD9. Collectively, our data and previously
published investigations of p130Cas tyrosine residues [6,18]
suggest that individual tyrosine phosphorylation events in the
Cas protein substrate domains confer discrete functional out-
comes.
The global alignment of the Cas family sequences revealed a
striking consensus between NEDD9 and p130Cas tyrosine
phosphorylation motifs (-YXXP-) in the substrate domains.
NEDD9 Y189 is one of 10 tyrosines that align with p130Cas
tyrosines and only 3 NEDD9 tyrosines (including Y214) show no
concordance. Interestingly, two tyrosines – NEDD9 Y166 and
NEDD9 Y317 - showed concordance in all 4 Cas proteins. The
p130Cas mouse tyrosine Y391 that aligns with NEDD9 Y317 has
previously been shown to be a substrate for Src kinase [6]. In
addition to the tyrosines, we note conservation of serine (S) 369
Table 1. Conservation of tyrosine phosphorylation consensus
motifs (-YXXP-) contained in Cas family protein substrate
domains.
Residue# NEDD9 P130Cas Efs HEPL
Y92-p TFGQQKLyQVPNPQA 4/4 3/4 1/3 3/4
Y106-p AAPRDTIyQVPPSyQ 4/4 – – –
Y118-p SYQNQGIyQVPtGHG 4/4 3/4 3/3 –
Y132-p GTQEQEVyQVPPSVQ 4/4 3/4 – –
Y166-p RTGHGYVyEYPSRYQ 4/4 4/4 3/3 4/4
Y177-p SRVQKDVyDIPPSHT 4/4 3/4 – –
Y189-p SHTTQGVyDIPPSSA 4/4 3/4 – –
Y214-p EIKPQGVyDIPPTKG 4/4 – – –
Y223-p IPPTKGVyAIPPSAC 4/4 4/4 3/3 2/4
Y241-p AGLREKDyDFPPPMR 3/4 – – –
Y261-p DLRPEGVyDIPPTCT 4/4 3/4 3/3 –
Y317-p VGSQNDAyDVPRGVQ 4/4 3/4 3/3 4/4
Y345-p PQERDGVyDVPLHNP 4/4 4/4 3/3 –
The amino acid residue number of the 13 NEDD9 YXXP motifs contained in the
human NEDD9 substrate domain (aas 59–399) are shown in the first column.
The surrounding sequence is shown in the second column. Numbers reflect
conservation of the tyrosine in the orthologues examined for each Cas family
protein. Human, mouse, rat and chicken orthologues were examined for all
family members with the exception of Efs which did not include the chicken
orthologue. Cases where no conservation was observed are indicated by a dash
(–).
doi:10.1371/journal.pone.0069304.t001
Table 2. Individual NEDD9 residue phosphorylation
frequency.
NEDD9
# records Residue Phospho-peptide
604 Y317 VGsQNDAyDVPRGVQ
491 Y166 RtGHGyVyEyPSRyQ
307 Y345 PQERDGVyDVPLHNP
271 Y92 TFGQQKLyQVPNPQA
205 Y241 AGLREKDyDFPPPMR
204 Y214 EIKPQGVyDIPPtKG
110 Y189 sHttQGVyDIPPSSA
69 Y177 SRyQKDVyDIPPsHt
60 Y629 ERSWMDDyDyVHLQG
47 Y631 SWMDDyDyVHLQGKE
25 Y261 DLRPEGVyDIPPTCT
20 Y164 PVRtGHGyVyEyPSR
12 Y132 GtQEQEVyQVPPSVQ
11 Y106 AAPRDTIyQVPPSyQ
11 S182 DVyDIPPsHttQGVy
10 Y223 IPPtKGVyAIPPsAC
7 Y118 SyQNQGIyQVPtGHG
7 Y168 GHGyVyEyPSRyQKD
7 Y172 VyEyPSRyQKDVyDI
5 T219 GVyDIPPtKGVyAIP
Ranked list showing numbers of mass spectrometry records of phosphorylation
at the indicated residue. Phospho-sites with ,5 records are not included. Data
from Phophositeplus (www.phosphosite.org).
doi:10.1371/journal.pone.0069304.t002
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NEDD9 in the p130Cas and HEPL human, mouse and rat
sequences. Previous studies have shown that this residue is critical
for NEDD9 targeting by the proteasome [19] and plays a role in
NEDD9-mediated cell spreading [20]. Leucine (L) 751 of NEDD9
that mediates binding to BCAR3/AND34/NSP2 [21] is con-
served in p130Cas and this site has recently been confirmed to
mediate the same interaction for p130Cas [22]. By contrast S296
that is phosphorylated by Aurora kinase [23] is unique to the
NEDD9 sequence. Thus the Cas family proteins appear to have
both overlapping and distinct site specific functions.
We have previously shown that mouse embryo fibroblasts
(MEFs) from NEDD92/2mice have faster rates of focal adhesion
disassembly and correspondingly migrate more rapidly on 2D
surfaces [3]. Consequently, this indicates that NEDD9 may
function to stabilize focal adhesions and thus regulate the rate of
cell migration. In the present study we show that mutation of
NEDD9 Y189 to disable phosphorylation of this residue both
increases cell migration speed. Conversely, the phosphomimetic
form, Y189D, significantly reduced cell migration speed. This
therefore suggests that Y189 may be required for NEDD9
stabilization of focal adhesions. The goal of our study was to
determine whether there is a functional equivalent of p130Cas
Y253 in the sequence of NEDD9 and we have indeed identified
that Y189 NEDD9 plays a specific role in NEDD9 stimulation of
cell migration. However, the two residues appear to play opposing
roles in regulating the migration phenotypes of their respective
proteins. Thus, while NEDD9 Y189F results in increased
migration relative to cells transfected with wild-type NEDD9,
p130Cas Y253F inhibited migration relative to cells expressing
wild-type p130Cas [6]. This may reflect different effects between
the two molecules on the rate of focal adhesion turnover. Previous
studies in MEFs have suggested that p130Cas expression induces
increased rates of focal adhesion turnover [24,25]. In contrast our
previous data have suggested that NEDD9 stabilizes focal
adhesions in MEFs [3]. Therefore the differences in effect between
Y253 p130Cas and Y189 NEDD9 are congruent with these
differential roles in adhesion stability. Currently, it is not known
what mediates this differential effect on focal adhesion turnover.
However, it is clear that despite the high similarity between the
substrate binding domains of these two proteins, they respond
differently to stimuli that induce tyrosine phosphorylation [15,26]
and mediate differential down-stream signalling pathway activa-
tion [2,27].
At present the protein(s) that associate with phosphorylated
Y189 NEDD9 are not known. Our data suggests that mutation of
this residue does not affect global tyrosine phosphorylation of
NEDD9. Therefore, it appears likely that phosphorylated Y189
may mediate interaction with a specific protein partner that is
required for NEDD9 stabilization of focal adhesions. Conceptu-
ally, the abundance of phosphorylation sites in both the p130Cas/
BCAR1 and NEDD9 substrate binding domains suggests the
possibility of redundancy among these sites. However, together
with our study, evidence is now mounting to suggest that at least
some individual sites may be necessary for discrete functions of
each molecule. Given the critical role of NEDD9 in the promotion
of cancer invasion [1], elucidation of NEDD9-specific and
NEDD9-unique phosphorylation-mediated interactions is likely
to be important for future assessment of NEDD9 as both a
prognostic indicator and therapy target in cancer.
Materials and Methods
Sequence Alignments and Phospho-peptide Data
Analysis
Global sequence alignment was performed using PRALINE
(http://www.ibi.vu.nl/programs/pralinewww/) [28]. The follow-
ing sequences were compared: NEDD9 Homo sapiens (AAH20686),
Mus musculus (NM_017464), Rattus norvegicus (NM_001011922),
Gallus gallus (XM_418946); p130Cas Homo sapiens (P56945), Mus
musculus (NM_009954), Rattus norvegicus (NM_012931), Gallus gallus
(XM_414057); Efs Homo sapiens (NP_005855.1), Mus musculus
(AAC52340.1), Rattus norvegicus (AAI61942); and HEPL Homo
sapiens (Q9NQ75), Mus musculus (AAI29977.1), Rattus norvegicus
(NP_001178673.1), Gallus gallus (XP_417499.2). Curated, publicly
available, high-throughput tandem mass spectrometry-derived
phosphorylation modification data from Phophositeplus (www.
phosphosite.org) [29] were analysed. Analysis was restricted to Cell
Signalling Technology curation set data and records were
manually screened for duplications (for example the same data
set appearing under separate categories of brain cancer and
glioblastoma). Records were grouped as brain (brain, glioblastoma
and glioma), breast (breast cancer, breast adenocarcinoma, breast
ductal carcinoma, breast cancer triple-negative), colorectal,
gastric, leukaemia (acute myeloid, chronic myeloid, acute
lymphocytic and chronic lymphocytic), liver and lung (lung,
non-small cell lung, non-small-cell squamous cell lung, small-cell
lung) cancers. Tumour cell types in which ,5 examples were
Table 3. Individual p130Cas residue phosphorylation
frequency.
p130Cas
# records Residue Phospho-peptide
662 Y128 SKAQQGLyQVPGPsP
607 Y249 APGPQDIyDVPPVRG
603 Y234 AQPEQDEyDIPRHLL
382 Y387 RPGPGtLyDVPRERV
272 Y287 RDPLLEVyDVPPsVE
255 Y267 SQyGQEVyDtPPMAV
192 Y327 PLLREEtyDVPPAFA
146 Y306 PsNHHAVyDVPPsVs
86 Y224 RVGQGyVyEAAQPEQ
85 Y410 GVVDSGVyAVPPPAE
61 T385 LRRPGPGtLyDVPRE
52 Y372 PPPAPDLyDVPPGLR
43 Y362 sPPAEDVyDVPPPAP
22 Y666 GWMEDyDyVHLQGKE
21 Y664 EGGWMEDyDyVHLQG
17 T326 GPLLREEtyDVPPAF
12 Y115 QPQPDSVyLVPTPSK
12 T269 yGQEVyDtPPMAVKG
11 S139 GPsPQFQsPPAkQTS
8 H552 LQKMEDVHQTLVAHG
6 Y222 PTRVGQGyVyEAAQP
5 Y192 AGMGHDIyQVPPSMD
5 S300 VEKGLPPsNHHAVyD
Ranked list showing numbers of mass spectrometry records of phosphorylation
at the indicated residue. Phospho-sites with ,5 records are not included. Data
from Phophositeplus (www.phosphosite.org).
doi:10.1371/journal.pone.0069304.t003
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Figure 2. NEDD9 mutations do not affect global tyrosine phosphorylation or targeting to focal adhesions. A. Schematic representation
of NEDD9 protein sequence showing the N-terminal SH3 domain, substrate domain containing 13 consensus tyrosine phosphorylation motifs (Y), the
serine rich domain (SRR) and the Focal Adhesion Targeting domain (FAT). The two mutated tyrosine residues are indicated in red in the Y189F and
Y214F schematic representations. B. Cells transfected with the indicated expression constructs were held in suspension (–) or suspended and then
plated onto fibronectin (+). NEDD9 immunoprecipitates were probed with antibodies to phosphotyrosine (P-Tyr) and with anti-NEDD9 antibodies
(GFP fusions). C. Cells transfected with GFP vector (A–C), GFP.NEDD9 (D–F), GFP.NEDD9 Y189F (G–I) and GFP.NEDD9 Y214F (J–L). Left hand panels
NEDD9 Phosphorylation and Cell Migration
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detected for at least one of the phospho-tyrosine residues were
excluded from the analysis.
Cell Culture and Antibodies
Immortalized mouse embryo fibroblasts (MEF) from homozy-
gous null NEDD9 (NEDD92/2) mice have been previously
described [3]. MEFs and MCF-7 breast cancer cells (as previously
used [31]) were maintained in Dulbecco’s Modified Eagles
Medium (DMEM) (Invitrogen) with 15% and 10% Foetal Bovine
Serum (FBS), respectively. MEF media was supplemented with
antibiotics (pen/strep, Invitrogen). Monoclonal antibodies to
NEDD9 (clone 2G9) were from ImmuQuest (Cleveland, UK),
monoclonal anti-phosphotyrosine antibody (clone 4G10) was
purchased from Upstate Millipore (CA, USA), anti-paxillin
antibody was from BD Transduction Laboratories (NW, USA).
Secondary HRP-conjugated anti-mouse and anti-rabbit antibodies
were either from Amersham (NJ, USA) and Cy3-conjugated anti-
mouse antibodies were purchased from Jackson Immunoresearch
(PA, USA).
Expression Constructs and Transfections
The GFP.NEDD9 fusion protein expression construct has been
previously described (Law et al., 2000) and was used as the
template to create single amino acid substitutions of tyrosine (Y) to
phenylalanine (F) by site-directed mutagenesis using the Quik-
change mutagenesis kit from Stratagene (La Jolla, CA). The
forward primer sequence to generate Y189F was 59-
GGGGTATTTGACATCCCTCCCTCATCAGCAAAAGGC-
39 and to generate Y214F was 59-GATAAAACCT-
CAAGGGGTGTTTGAGCATCCCGCCTACAAAAGGG-39.
Forward primers and the matched reverse complementary primers
were purchased from Sigma (USA). Generation of the Y189D
mutant construct was performed by Genscript (NJ, USA). All
cDNA constructs were sequenced in both directions to confirm
sequence fidelity. Transient transfection of MEF cells was achieved
using a nucleofector (Amaxa) and MEF2 nucleofector kit, as per
the manufacturer’s protocol (Integrated Sciences). MCF-7 cells
were transfected using Lipofectamine 2000 as per the manufac-
turer’s instructions (Invitrogen Corporation, CA, USA).
Protein Extraction, Immunoblotting, Cell Suspension and
Immunoprecipitation
Conditions of protein extraction and immunoblotting were
carried out as previously described [30]. Adhesion to fibronectin to
stimulate NEDD9 tyrosine phosphorylation was achieved essen-
tially as previously described [31,32]. Briefly, after transfection,
MCF-7 cells were serum starved overnight, and the following day
cells were detached by 15 minutes incubation with 3 mM EDTA
in PBS at 37uC. Cells were resuspended in serum-free DMEM and
incubated on bacterial petri dishes (to prevent adhesion) for 2
hours. Cells were then either extracted after 2 hours (suspension
conditions) or replated onto fibronectin coated dishes in serum-
free media for 2 hours. Proteins from cells grown in suspension or
adhered to fibronectin were extracted in NP-40 lysis buffer
(10 mM Tris-HCL pH7.5, 5 mM EDTA, 50 mM NaF, 1% v/v
Nonidet P-40, 0.05% w/v SDS and 0.25% v/v sodium
deoxycholate; extraction buffer freshly supplemented with 2 mM
Na3VO4, 1 mM PMSF, 10 mg/ml Leupeptin, 10 mg/ml Aprotinin
immediately prior to extraction). Extracted NEDD9 proteins were
immunoprecipitated with anti-NEDD9 antibodies coupled to
protein A Sepharose (Sigma, MO, USA).
Live and Fixed Cell Imaging
Cells were grown in 35 mm glass bottom dishes (MatTek) in
recording media (CO2-independent media (Invitrogen), supple-
mented with 15% FBS and pen-strep). Immediately prior to
show GFP fluorescence images, middle panels show paxillin immunostaining and merged images are shown on the right. Arrows point to examples
of positive focal adhesions. Each image shows a cropped region of one cell.
doi:10.1371/journal.pone.0069304.g002
Figure 3. Mutation of NEDD9Y189 stimulates faster cell migration. A. 10 representative migration traces of NEDD92/2 fibroblast cells
transfected with the indicated GFP expression plasmids. B. MSD calculated from trajectories of cells expressing exogenous NEDD9 (black squares),
NEDD9 Y189F (white triangles) and Y214F (white circles). C. Average speed of NEDD92/2 fibroblasts transfected with the indicated GFP expression
plasmids. Graphs show the average (n.50 cells per expression construct) and SEM. **p,0.01, NS =not significant.
doi:10.1371/journal.pone.0069304.g003
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imaging, recording media was supplemented with Oxyrase
(Oxyrase, Ohio, USA) (60 ml per 2 mL media). Time-lapse images
were captured using an ORCA ERG cooled CCD camera
(Hamamatsu, SDR Clinical Technology NSW, Australia) and
Olmypus IX81 inverted microscope equipped with an environ-
mental chamber heated to 37uC. For assay of focal adhesion
dynamics and random cell motility glass bottom dishes were pre-
treated with poly-L-lysine (50 mg/mL) and then coated with a
solution of fibronectin (20 mg/mL) for 2 hours at 37uC. For fixed
imaging, cells were fixed in 4% PFA in PBS for 10 minutes,
permeabilised (0.2% v/v Triton X-100, 0.5% w/v BSA in PBS)
and then immunostained. Imaging of fixed cells was performed
with the Olympus IX81 inverted microscope.
Migration Analysis
Transmitted light images of MEF cells, or fluorescence images
of GFP-transfected MEF cells, were captured every 8 minutes for
160 mins, (406 objective). Cells undergoing division or apoptosis
were excluded from analyses and random migration analyses were
performed on sparsely plated cultures. Post image capture, nuclear
translocation was tracked in time-lapse stacks using Metamorph
V6.3 software (Molecular Devices). Generation of migration traces
and the calculation Mean Squared Displacement and cell speeds
were performed as previously described [3]. Measurements were
performed with Metamorph V6.3 software, calculations were
performed in Microsoft Excel and graphs generated in GraphPad
Prism.
Measurement of Focal Adhesion Dynamics and Lengths
GFP-NEDD9-positive focal adhesions were imaged with an
Olympus IX81 inverted microscope, with a 60X (NA 1.35) oil
objective, using fluorescence filters of BP 460–495/BP510–550
(GFP). Images were captured every 2 minutes for 90 minutes total,
250 ms exposure times. Focal adhesions at the protruding edge of
the membrane were analysed by measuring the temporal changes
in integrated pixel intensity of an individual focal adhesion.
Quantification of adhesion dynamics was performed as previously
described [3] with data from .25 adhesions pooled from each of
3–5 cells per construct. Lengths of focal adhesions at the
protruding edge were measured on calibrated images.
Figure 4. Mutation of NEDD9Y189 stimulates faster adhesion dynamics. A. Time-lapse microscopy of the assembly and disassembly of GFP-
positive focal adhesions. Shown are examples of focal adhesions in NEDD92/2MEFs transfected with GFP.NEDD9, GFP.NEDD9Y189F and GFP.NEDD9
Y214F. Each box shows a 4.7 mm64.7 mm cropped region. Arrows point to each adhesion at the time of peak fluorescence intensity. B. Focal adhesion
assembly rate constants (k) for the indicated fusion proteins. C. As for B, except data showing the disassembly rate constants (k). N.25 individual
adhesions were analysed per condition. *p,0.05, N.S. = not significant.
doi:10.1371/journal.pone.0069304.g004
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Image Preparation
Final micrograph images and grey level adjustments were
prepared in Adobe Photoshop.
Statistical Analysis
All error bars on histograms show the standard error of the
mean (SEM). Statistical comparison of two means was performed
in Graph Pad Prism using a Student’s t test and for greater than
two means using one-way ANOVA with Tukey’s Multiple
Comparison Test.
Supporting Information
Figure S1 Cas family proteins sequence alignment.
Sequences aligned at the PRALINE website.
(PDF)
Figure 5. NEDD9Y189D phospho-mimetic inhibits migration and increase focal adhesion lengths. A. Schematic representation of
NEDD9 protein sequence showing the Y189D mutation. B. NEDD92/2 MEFs transfected with GFP.NEDD9 or GFP.NEDD9Y189D, as indicated. Arrows
point to examples of positive focal adhesions. Scale bar = 20 mm. C. Average speed of NEDD92/2 fibroblasts transfected with the indicated GFP
expression plasmids. Graphs show the average (n.100 cells per expression construct) and SEM. ***p,0.001. D. Fraction of focal adhesions versus
adhesion length. Data for GFP.NEDD9 show in black circles (n = 112) and for GFP.Y189D in white circles (n = 96). E. Comparison of the fraction of focal
adhesions less than 4 mm long. ***p,0.001.
doi:10.1371/journal.pone.0069304.g005
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